Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10.
Effects of Physical Exercise on Neuroinflammation, Neuroplasticity, Neurodegeneration, and Behavior: What We Can Learn From Animal Models in Clinical Settings.
Self-Efficacy as a Longitudinal Predictor of Perceived Cognitive Impairment in Individuals with Multiple Sclerosis.
Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial.
Paracaspase MALT1 Deficiency Protects Mice from Autoimmune-Mediated Demyelination.
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate.
Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity.
Risk of fractures in patients with multiple sclerosis: A population-based cohort study.
The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitis.
Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot study.
Interleukin-6 control of early Theiler's Murine Encephalomyelitis Virus replication in macrophages occurs in conjunction with STAT1 activation and nitric oxide production.
Cerebrospinal fluid myelin basic protein is frequently ordered but has little value: a test utilization study.
Determinants of ligand binding and catalytic activity in the myelin enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase.
Biointegrator announced that it has successfully launched Neskler® - a first generic of Gilenya® in Russia and EuroAsian Economic Union
Effects of fingolimod in relapsing-remitting multiple sclerosis.
Initiating oral fingolimod treatment in patients with multiple sclerosis.
Promotion and prevention of autoimmune disease by CD8+ T cells.
A simple test of choice stepping reaction time for assessing fall risk in people with multiple sclerosis.
Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents.
Human Umbilical Cord Stem Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Immunoinflammation and Remyelination.
[Anti-MOG antibody in different types of immune-mediated optic neuritis].
Sexual disparities in the incidence and course of MS.
Electrophysiological markers and predictors of the disease course in primary progressive multiple sclerosis.
[Retrospective study of clinical features of neuromyelitis optica spectrum disease with connective tissue disease].
A Pilot Study: examining the effects and tolerability of structured dance intervention for individuals with multiple sclerosis.

Pages